Technical
Channels

Drug Discovery

Drug Development

Drug Manufacturing

Drug Delivery

Clinical Trials

Regulatory and Legal

Alliances and Mergers

QA/QC and Compliance

Pharmaceutical Processing and Packaging

Change text size [+] [-]

Reproducible Cell Migration Screening Assay

Tuesday, June 30, 2009
 Email This |  Printer Friendly

AMSbio has announced two-dimensional cell-based assay kits for reproducibly screening test compounds that may stimulate or inhibit adherent cell migration.

The OrisCell Migration Assay provides a method that is less labour intensive, allows for real-time imaging, and is amenable to high throughput and high content imaging instruments. Unlike traditional cell migration assays using a Boyden chamber device, there is no transmembrane or cell culture insert obstructing live images of the cells as they migrate.

The assay uses a multi-step process that starts with the attachment (optional) of a detection mask to the bottom of the wells of a 96-well assay microplate. A specially designed, cell seeding stopper fitted inside of each microplate well restricts cells from seeding into a central detection zone as cells are being dispensed. After cell attachment has occurred (4-28 hrs), the stoppers are removed, allowing cells to freely migrate into the detection zone of the wells. Cells can be labeled pre- or post-migration. Cells that have not migrated into the detection zone are blocked from view by the mask initially applied to the plate bottom. Migrated cells may then be analyzed by using a fluorescence plate reader.


Share this:   Del.icio.us | 
Digital Edition



Singapore's Preclinical R&D industry should differentiate itself in Asia by competing on quality rather than on price.
Yes
No
View results


ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US

© 2010 Ten Alps Communications Asia. All rights reserved.
Use of this Web site is subjected to its Terms and Conditions of Use. View our Privacy Policy